David O'Toole
Director Financiero/CFO en AVITA MEDICAL, INC. .
Fortuna: 155 492 $ al 30/04/2024
Cargos activos de David O'Toole
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AVITA MEDICAL, INC. | Director Financiero/CFO | 15/06/2023 | - |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Corporate Officer/Principal | - | - |
California Society of Certified Public Accountants | Corporate Officer/Principal | - | - |
Southern California Biomedical Council
Southern California Biomedical Council Miscellaneous Commercial ServicesCommercial Services Southern California Biomedical Council, also known as SoCalBio, is an organization that aims to promote the growth and development of the life sciences industry. The non-profit company is based in Los Angeles, CA. The company provides leadership, advocacy, and support to their members, and foster collaboration within the industry. The CEO of the company is Ahmed Enany. | Corporate Officer/Principal | - | - |
Historial de carrera de David O'Toole
Antiguos cargos conocidos de David O'Toole.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
OPIANT PHARMACEUTICALS, INC. | Director Financiero/CFO | 12/09/2017 | 02/03/2023 |
Secretario Corporativo | - | 02/03/2023 | |
SOLENO THERAPEUTICS, INC. | Director Financiero/CFO | 09/07/2014 | 11/09/2017 |
MEDICINOVA, INC. | Director/Miembro de la Junta | 10/04/2012 | 16/06/2014 |
Independent Dir/Board Member | 10/04/2012 | 16/06/2014 | |
CODEXIS, INC. | Director Financiero/CFO | 04/09/2012 | 01/06/2014 |
RESPONSE GENETICS, INC | Director Financiero/CFO | 03/05/2010 | 20/08/2012 |
░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░ ░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formación de David O'Toole.
University of Arizona | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 15 |
Operativa
Director of Finance/CFO | 6 |
Corporate Officer/Principal | 5 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 8 |
Commercial Services | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 5 |
---|---|
RESPONSE GENETICS, INC | Health Technology |
MEDICINOVA, INC. | Health Technology |
CODEXIS, INC. | Process Industries |
SOLENO THERAPEUTICS, INC. | Health Technology |
AVITA MEDICAL, INC. | Health Technology |
Empresas privadas | 8 |
---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Commercial Services |
California Society of Certified Public Accountants | |
California Healthcare Institute | Health Technology |
Southern California Biomedical Council
Southern California Biomedical Council Miscellaneous Commercial ServicesCommercial Services Southern California Biomedical Council, also known as SoCalBio, is an organization that aims to promote the growth and development of the life sciences industry. The non-profit company is based in Los Angeles, CA. The company provides leadership, advocacy, and support to their members, and foster collaboration within the industry. The CEO of the company is Ahmed Enany. | Commercial Services |
Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
Arthur Anderson & Co. |
- Bolsa de valores
- Insiders
- David O'Toole
- Experiencia